RADIONETICS ONCOLOGY
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications, is poised to capitalize on the increasing demand for novel radiotherapeutics.
RADIONETICS ONCOLOGY
Social Links:
Industry:
Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
California City, California, United States
Country:
United States
Status:
Active
Total Funding:
30 M USD
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Private Equity Round - Radionetics Oncology
5AM Ventures
5AM Ventures investment in Private Equity Round - Radionetics Oncology
Key Employee Changes
Date | New article |
---|---|
2022-04-12 | Radionetics Oncology Appoints Nishan de Silva, M.D. as Chief Executive Officer |